MAPT and Alzheimer disease: In line with this, many of the antibodies displayed strong immunoreactivity with AD brain Tau, with signals detected across the entire MW range, indicating the presence of monomeric, oligomeric and PHF-Tau species, as well as Tau fragments (Supp.